George Simeon, Curevo Vaccine CEO
Curevo gets $110M for a shot against Shingrix, gets Moncef Slaoui and Tal Zaks on board
A Seattle biotech trying to take on one of the world’s biggest vaccines has nabbed a megaround. It also named former Operation Warp Speed chief …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
